Analytical Data
-
Gene name
hmwC
- Application
-
Alternative Names
Putative accessory processing protein
-
Species
Yersinia pestis
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A0H2W148
-
Expression Region
1-584aa
-
Molecular Weight
73.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HMWC (High Molecular Weight Complex) recombinant proteins have garnered significant attention in the field of biotechnology and pharmaceuticals due to their promising applications in various therapeutic and industrial processes. The research surrounding HMWC focuses on understanding the structure, function, and production of these proteins, which often exhibit unique biochemical properties that can be harnessed for improved efficacy in drug delivery, enzyme catalysis, and biomaterial development. The challenge in studying HMWC lies in their complex and often unstable nature, necessitating advanced techniques in protein engineering and expression systems to achieve optimal yields and activity. Recent advancements in genetic engineering, such as CRISPR/Cas9 and novel expression platforms, have enabled researchers to produce HMWC with enhanced stability and functionality. Additionally, investigations into the interactions of HMWC with other biomolecules have revealed their potential roles in cellular processes, opening new avenues for therapeutic intervention in diseases. As the biotechnology sector continues to evolve, the exploration of HMWC recombinant proteins holds the promise for innovative solutions in healthcare and environmental applications, making it a vibrant area of ongoing research.
